Louisiana HB277 mandates that educational or marketing materials for prescription drugs directed to healthcare providers include price information.
HB277 requires that any person providing educational or marketing materials related to a prescription drug to a healthcare provider include price information in the materials. The price information must include the date the materials were prepared, the average wholesale price of a 30-day supply of the drug, or the proposed duration and average wholesale price for a shorter period if the drug is designed for less than 30 days of therapy. The materials must also disclose if there is a biosimilar or generic drug available for the same disease state.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.